Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    18 October 2023

    Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing

    Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target events across t...

    18 October 2023

    Semarion announces Early Adopter Programme for SemaCyte Microcarrier Platform

    SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery Early access will further validate the technology and provide feedback on applicability across customer workflows Cambridge, UK, 18 October 2023: Sema...

    17 October 2023

    National Lottery funding enables leap forward in strategy for children’s brain tumour charity, Tom’s Trust

    The National Lottery Community Fund has granted children’s brain tumour charity Tom’s Trust more than £400,000, enabling a big leap forward in its strategy to support more families. ...

    17 October 2023

    Neurodiversity, burnout, and poorer dietary choices: a closer look on employee health

    Workplaces play an important role in influencing the health of staff. We spend lots of hours at work. According to the TUC analysis, workers in the UK are putting in the longest hours in the EU. ...

    17 October 2023

    Springboard welcomes Alex Vasiev in his new role

    Springboard Pro, a leading engineering consultancy company based in Cambridge, UK, is pleased to announce the addition of Alex Vasiev to the team as a business development manager and engineer. With a wealth of experience and expertise in device development, Alex is set to bring valuabl...

    13 October 2023

    Astex CSO David Rees Honoured as a Hero of Chemistry by the American Chemical Society

    Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, congratulates its Chief Scientific Officer (CSO), David Rees PhD, FMedSci, FRSC on bein...

    18 October 2023

    Cognidox announces new e-signature integration with DocuSign

    Cognidox already has a built in 'best in class' FDA 21 CFR part 11 compliant e signature solution. We have now added DocuSign integration to make contract management and 3rd party signing of documents even easier. ...

    17 October 2023

    Outside the box: scale up your ambitions with a Guardtech Cleanrooms modular

    The Guardtech Group’s modular champions are offering flexible solutions that grow and adapt alongside their clients’ aspirations. ...

    16 October 2023

    Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

    Cardiff, UK and Massachusetts, US - Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company developing methods to engineer improved and more developable therapeu...

    16 October 2023

    Cam AI is offering free CBT sessions for 18-24 years olds

    Cam AI writes... Suffering with anxiety and struggling to get support? Cam AI, a mental health startup, is offering volunteers free Cognitive Behavioural Therapy sessions for anxiety with our accredited therapists*. Our team is currently conducting data collection and research to buil...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 164
    • Page 165
    • Current page 166
    • Page 167
    • Page 168
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS